The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
The new logo incorporates three beating hearts seamlessly & reinforces 'healthcare with a heart' into the Group's visual identity
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Subscribe To Our Newsletter & Stay Updated
